All News #Library
Biotech
Endeavor Bio Granted EMA PRIME Designation For Taladegib
03 Nov 2025 //
BUSINESSWIRE
Endeavor Biomedicines Releases Positive Phase 2a Data
30 Sep 2025 //
BUSINESSWIRE
Endeavor Bio` Ph 2a Taladegib Results at ERS Congress 2025
10 Sep 2025 //
PHARMAWEB
Endeavor Shows New Phase 2a ENV-101 Data in IPF Patients
20 May 2025 //
BUSINESSWIRE
Endeavor BioMedicines Doses 1st Patient in Ph 2b WHISTLE-PF Trial
20 Nov 2024 //
BUSINESSWIRE
Endeavor BioMedicines Appoints Bill Bradford, M.D., Ph.D., to Board of Directors
12 Sep 2024 //
BUSINESSWIRE
Endeavor signs $430M deal for Hummingbird’s HER3-targeted ADC
20 Oct 2023 //
FIERCE BIOTECH

Market Place
Sourcing Support